
Materials & Chemicals · NSE / BSE
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in producing structure directing agents, phase transfer catalysts, pharmaceutical and agrochemical intermediates, and other specialty chemicals, and is among the largest producers of SDAs for zeolites in India. The company caters to a wide range of industries including automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceuticals, personal care, and others, with products sold in India and exported to over 25 countries such as the USA, Germany, South Africa, China, and the UK. Exports contributed around 76% of its revenue in FY 2020, and its customer base includes leading names like Merck, Bayer AG, Laurus Labs, Navin Fluorine, Atul Limited, SRF Limited, and Divi’s Laboratories, with manufacturing facilities located at Ankleshwar and Dahej in Gujarat.
Price Band
₹1073 – ₹1083
Issue Size
₹500 Cr
Lot Size
13 shares
GMP
+102.5%
Est. Listing
₹2193
at current GMP
Subscribed
—
Open
16 Jul 2021
Close
20 Jul 2021
Allotment
26 Jul 2021
Refund
27 Jul 2021
Demat Credit
28 Jul 2021
Listing
29 Jul 2021
Designated Registrar: Link Intime India Private Limited
Allotment Date
26 Jul 2021
Basis finalization
Refunds Initiate
27 Jul 2021
Mandate release
Demat Credit
28 Jul 2021
Shares in demat
Listing Debut
29 Jul 2021
Trading begins
Tatva Chintan Pharma Chem Limited is bringing an initial public offering (IPO) in the Materials & Chemicals sector with an aggregate issue size of ₹500 Crores. The shares are offered at a price band of ₹1073 to ₹1083 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 13 shares (approx. ₹14,079 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2021-07-28, while un-allotted funds or UPI block mandates will be released on 2021-07-27.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.